Neumann, Roland P; Gerull, Roland; Hasler, Pascal W; Wellmann, Sven; Schulzke, Sven M (2024). Vasoactive peptides as biomarkers for the prediction of retinopathy of prematurity. (In Press). Pediatric research Nature Publishing Group 10.1038/s41390-024-03091-w
|
Text
s41390-024-03091-w.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (701kB) | Preview |
BACKGROUND
Retinopathy of prematurity (ROP) is a major complication in preterm infants. We assessed if plasma levels of midregional pro-atrial natriuretic peptide (MR-proANP) and C-terminal pro-endothelin-1 (CT-proET1) serve as early markers for subsequent ROP development in preterm infants <32 weeks gestation.
METHODS
Prospective, two-centre, observational cohort study. MR-proANP and CT-proET1 were measured on day seven of life. Associations with ROP ≥ stage II were investigated by univariable and multivariable logistic regression models.
RESULTS
We included 224 infants born at median (IQR) 29.6 (27.1-30.8) weeks gestation and birth weight of 1160 (860-1435) g. Nineteen patients developed ROP ≥ stage II. MR-proANP and CT-proET1 levels were higher in these infants (median (IQR) 864 (659-1564) pmol/L and 348 (300-382) pmol/L, respectively) compared to infants without ROP (median (IQR) 299 (210-502) pmol/L and 196 (156-268) pmol/L, respectively; both P < 0.001). MR-proANP and CT-proET1 levels were significantly associated with ROP ≥ stage II in univariable logistic regression models and after adjusting for co-factors, including gestational age and birth weight z-score.
CONCLUSIONS
MR-proANP and CT-proET1 measured on day seven of life are strongly associated with ROP ≥ stage II in very preterm infants and might improve early prediction of ROP in the future.
IMPACT
Plasma levels of midregional pro-atrial natriuretic peptide and C-terminal pro-endothelin-1 measured on day seven of life in very preterm infants show a strong association with development of retinopathy of prematurity ≥ stage II. Both biomarkers have the potential to improve early prediction of retinopathy of prematurity. Vasoactive peptides might allow to reduce the proportion of screened infants substantially.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine |
UniBE Contributor: |
Gerull, Roland |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0031-3998 |
Publisher: |
Nature Publishing Group |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
28 Feb 2024 14:43 |
Last Modified: |
28 Feb 2024 14:52 |
Publisher DOI: |
10.1038/s41390-024-03091-w |
PubMed ID: |
38402317 |
BORIS DOI: |
10.48350/193248 |
URI: |
https://boris.unibe.ch/id/eprint/193248 |
Actions (login required)
 |
Edit item |